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INTRODUCTION
The first drug to be found useful in suppressing appetite was
amphetamine (Lesser and Meyerson, 1938). Amphetamine has potent
central stimulant, cardiovascular, hyperthermic and anorectic pro-
perties, to all of which tolerance develops upon repeated use. The
need for a more selective anorectic drug without the dangers of
abuse and toxicity prompted numerous studies into the anorectic
activity of a number of related compounds, all based upon the phen-
ethylamine molecule. This led to the development of fenfluramine
l-(3-trifluoromethylphenyl)-2-ethylaminopropane (Alphin et al., 1964).
Fenfluramine provided the appetite suppression characteristic of
amphetamine without producing the central stimulation.
The structural formulas of amphetamine and fenfluramine are
illustrated in Figure 1. It can be seen that the basic difference
between these molecules is the addition of an ethyl group on the nitro-
gen atom and the substitution of a trif luoromethyl group on the phenyl
ring.
CH2-CH-NH2
CH-,
CH9-CH-N^
H
CH 3 C2H 5
AMPHETAMINE FENFLURAMINE
Fig. 1. Structural formulas of amphetamine and fenfluramine.
Several approaches have been used to establish the pharma-
cological identities of amphetamine and fenfluramine. One such
approach has been the use of drug discrimination paradigms. Drug
discrimination learning requires the drug to produce a perceivable
change in some aspect of the organism's internal environment. By
producing this interoceptive cue, the drug versus saline injections
may then be applied as distinct discriminative stimuli, thus making
it possible to train animals to perform one type of behavior for
reinforcement following a drug injection and to perform a different,
but topographically similar behavior following injection of saline.
In the majority of drug discrimination studies, the animal is
required to either make opposite turns in a T-maze (Overton, 1978) or
opposite choices in a two lever test chamber (Colpaert et al., 1976).
Differential, but equivalent responses have also been trained in
other test procedures, such as the Lashley jumping stand (Brown et al.,
1968) and choices between side compartments of a 3-chambered apparatus
(Schechter and Roescrans, 1973). The incentive for the correct res-
ponse in these studies has either been food reward or escape from
shock. When acquisition of such response differentiation is reliably
shown, the drug is said to produce a discriminative stimulus.
Amphetamine has been extensively investigated in drug discrimin-
ation procedures. In brief, the results of testing a number of
neurochemical agents for their ability to antagonize the amphetamine
cue suggests no clear role of acetylcholine, norepinephrine or sero-
tonin (Ho and Huang, 1975). The amphetamine cue was successfully
3antagonized by pimozide (Ho and Huang, 1975) and by haloperidol
(Schechter and Cook, 1975), two dopamine receptor blockers. It was
also shown that alpha-methyl-para-tyrosine, the catecholamine
synthesis inhibitor (Kuhn et al., 1974; Rosecrans et al.
,
1973),
but not disulfiram, the dopamine-beta-hydroxylase inhibitor
(Schechter and Cook, 1975) was capable of antogonizing amphetamine's
discriminative property. These results suggest involvement of the
dopaminergic system in the discriminative stimulus property of
amphetamine.
Despite reports of some amphetamine-like effects of fenflur-
amine (Everitt and Hackett, 1972; Clineschmidt et al., 1975; Taylor
et al., 1973), evidence indicates that the interoceptive cues pro-
duced by fenfluramine are very different from those produced by
amphetamine. Schechter and Rosecrans (1973) reported that in rats
trained to discriminate 3 mg/kg amphetamine from saline, 4-8 mg/kg
fenfluramine failed to generalize to the amphetamine cue. Similarly,
it was found that rats trained to discriminate 3 mg/kg fenfluramine
from saline failed to generalize to amphetamine at doses between 0.25
and 1 mg/kg (Goudie, 1977). These results suggest that different
pharmacological mechanisms underlie the interoceptive cues produced
by amphetamine and fenfluramine.
Since fenfluramine has been shown to exert a selective action on
brain 5-hydroxytryptamine (5-HT, serotonin) concentrations (Opitz
,
1967; Costa et al., 1971; Duhault and Boulanger, 1977; Clineschmidt
et al.
,
1978), presumably by stimulating the release of 5-HT and
4blocking its reuptake at the neuronal synapse (Fuxe, 1975), it has
been suggested that many of the behavioral changes induced by fen-
fluramine depend upon alterations in the 5-HT system. For example,
it has been shown that 5-hydroxytryptophan (5-HTP), the precursor
of 5-HT, mimics the anorectic (Blundell and Leshem, 1975) and hypo-
thermic (Jespersen and Scheel-Kruger
, 1970) effects of fenfluramine.
It has also been reported that 5-HT receptor blocking drugs such as
methergoline (Funderburk et al., 1971; Jespersen and Scheel-Kruger,
1973) or cyproheptadine (Kruk, 1973) or methysergide (Jespersen and
Scheel-Kruger, 1970; Blundell et al., 1973) antagonize the anorectic
effects of fenfluramine. Moreover, electrolytic lesions of the mid-
brain raphe nuclei, an important site of origin of 5-HT neurons in
the brain (Dahlstrom and Fuxe, 1964), abolished the anorexia pro-
duced by fenfluramine (Samanin et al., 1972).
In the light of the present pharmacological, biochemical and be-
havioral knowledge of fenfluramine, it seemed reasonable to suspect
that the 5-HT system might be involved in the discriminative property
of fenfluramine. More specifically, the action underlying the dis-
criminative cue might consist of an indirect activation of the 5-HT
system, because promotion of 5-HT release and the inhibition of its
reuptake are known to increase synaptic concentrations of the trans-
mitter substance.
The studies that are reported here are behavioral pharmacological
investigations aimed at providing further information about the pharm-
acological identity of fenfluramine. The first phase of our research
5involved identification of the stimulus parameters produced by the
administration of fenfluramine. Once this was established, I sought
to explore the involvement of 5-HT in the discriminative stimulus
property of fenfluramine. This involved a series of generalization
and antagonism studies with serotonergic agents whose neuronal mech-
anisms of action are understood.
METHOD AND PROCEDURE
Subjects
.
The subjects used in this experiment were 24 Holtzmann male
albino rats obtained from the Holtzmann Co., Madison, Wisconsin.
Each rat, weighing between 250-350 g at the start of the exper-
iment, was housed in a cage measuring 24 X 18 X 19 cm in a temp-
erature-controlled room with an alternating 12 hour light/12 hour
dark cycle. Water was freely available to all rats.
Apparatus
.
The behavioral apparatus consisted of two standard Skinner
boxes housed in light-proof, sound attenuated and fan ventilated
chambers. Each Skinner box was equipped with two levers, one of
which was placed on the right and the other on the left of a cen-
trally placed dipper which delivered 0.1 cc of a liquid food rein-
forcement for three seconds. The food was a 50/50 mixture of
condensed milk and water, added to an equal volume of liquid Similac
Standard electromechanical programming and cumulative counters were
used to control and record behavior.
6Drugs.
Fenfluramine hydrochloride (Robbins), fluoxetine hydrochloride
and p-fluoroamphetamine hydrochloride (Eli Lilly), methysergide
maleate (Sandoz) and cinanserin hydrochloride (Squibb) were gen-
erously donated. 5-hydroxytryptophan (Sigma) and p-chloroampheta-
mine hydrochloride (Regis) were purchased. All drugs were dissolved
in 0.9% saline and were administered intraperitoneal^ (i.p.) in a
volume of 2 cc/kg body weight.
Preliminary training
.
Twelve rats were randomly assigned to each box. Discrimination
training was done according to standard shaping procedures. Once
lever pressing was well established, the animals (18 hours food de-
prived were trained to alternate between bars (only one bar was
reinforced for 5 minutes, then the other, for a total of 30 minutes)
When the animals began to alternate promptly following cessation of
reinforcement, the reinforcement schedule was gradually increased
to FR 10.
Discrimination training.
Next, the animals were trained to discriminate between 3 mg/kg
fenfluramine and physiological saline. Six out of the 12 rats
assigned to each box, randomly selected, were assigned the left
lever as "drug-correct" and the right lever as "saline-correct",
while the order was reversed for the remaining 6 animals. All
training and testing was done at the same time of the day, one hour
7before the daily feeding, for at least five consecutive days each
week. Throughout the study, the feeding schedule (15-20 grams of
standard Purina laboratory chow) maintained individual animals at
80 ± 5 % of normal body weight.
At the beginning of each session, each animal was injected
with fenfluramine or saline 60 minutes prior to training. During
testing, the following measures were recorded: the number of in-
correct responses before the first reinforcement (errors), and
the total number of responses at each lever. Discrimination
sessions were 10 minutes in duration, at the end of which the
animal was returned to its home cage. After 8 sessions of alter-
nating saline and drug injections, the operant lever was varied
according to the following two pseudorandom sequences:
fenfluramine-saline-saline-fenfluramine-fenfluramine
and
saline- f enf luramine-f enf luramine-saline-saline
Discrimination sessions were continued until all animals reached the
criterion of no more than 3 incorrect responses before the first rein-
forcement on each of 9 out of 10 consecutive days.
Test sessions .
Once drug discrimination was well established, a series of gen-
eralization and antagonism studies were conducted. On test days, the
reinforcement delivery system was disconnected (extinction), and the
following measures were recorded: the lever on which the rat first
8made 10 responses (the selected lever), and the number of responses
on the other lever before the 10th response was executed. As soon
as the rat responded 10 times to either lever, or after 10 minutes
had expired, testing was terminated and the rat was immediately re-
moved from the experimental chamber.
Between test days, the animals were required to discriminate
3 mg/kg fenfluramine from saline on 4 consecutive days, each day
with 3 or fewer errors. These retraining sessions, 10 minutes in
duration, were in the order of saline-fenfluramine-f enf luramine-
saline. If any animal failed to reach criterion, testing with that
animal was postponed and discrimination training continued until
that subject reached criterion.
Data analysis
.
During novel drug testing, there is really no correct or incor-
rect lever, and the experimenter cannot know in advance how the an-
imal will respond. For this reason, I immediately removed the rat
from the experimental chamber as soon as it responded 10 times to
either lever. At that time, the number of responses on either lever
was recorded and the percent f enf luramine-correct lever selection
for each animal was computed.
This procedure takes into account the "certainty" with which
an animal selects a lever. Animals trained on a fixed-ratio schedule
have to emit a certain number of responses before reinforcement can
follow. Well trained animals make the necessary 10 presses on the
correct lever with very few presses on the incorrect lever. There is
9an obvious difference between two animals, one of which presses the
drug-correct lever with no errors and the other which emits the re-
quired number of responses interspersed with, say, 8 presses at the
incorrect lever. The lever selection measure accounts for such a
difference.
Unless otherwise indicated, each data point represents the mean
(± 1 SEM) percent fenf luramine-correct responding for 10 subjects,
randomly selected from the available pool of animals, with the con-
straint that the rats were evenly distributed in terms of lever
assignment,
RESULTS AND DISCUSSION
Acquisition and maintenance of saline-fenfluramine discrimination
.
All subjects were run for at least 260, but not more than 315
operant sessions, except for one subject which was found dead in its
cage on the day of its 38th operant session.
The number of training sessions required for subjects to reach
discrimination criterion ranged from 14 to 55 (including the 10 cri-
terion sessions), with a median value of 22.
Following the initial training period, discrimination sessions
were conducted at least 4 times per week on further standard ses-
sions and all animals reliably selected the appropriate lever after
saline or fenfluramine treatment. Incorrect lever selections occurred
rarely and each individual rat reached a highly significant level
(one-tailed; p < 0.001; binomial test) of correct level selection.
The median percent-correct lever selection value was 100% for each
10
animal under either drug or saline treatment.
Averaged over the first 3 post-criterion saline treatments, the
mean ± 1 SEM response output ranged from 390 ± 17.3 to 1037 ± 88.3,
with a median value of 648 responses per 10 minute training session.
For fenfluramine treatments, this value ranged from 170 ± 28.8 to
977 ± 25.2, with a median value of 501 responses per 10 minute
training session. The individual response lever over these 3 fen-
fluramine treatments (expressed as a percentage of the corresponding
saline value) varied from 42.6 to 121 %, with a median value of
82.7 % and a mean value of 78.2 ± 5.6 %. This response decrease pro-
duced by 3 mg/kg fenfluramine was statistically significant (one-
tailed; p < 0.005; Wilcoxon-test)
.
Experiment 1, the time course of drug action
Initially, I hypothesized that establishment of the optimum
stimulus parameters would contribute to the sensitivity in the inves-
tigation of drug interactions in the discrimination procedure. In
particular, in studies involving drug antagonists, it is crucial to
find the point at which the drug cue is most easily manipulated. For
that reason, we next investigated the temporal parameters of the fen-
fluramine cue. This involved administering a 3 mg/kg dose of fenflur-
amine at various times prior to testing.
It can be seen in Fig. 2 that the fenfluramine cue shows a
relatively fast onset, with greater than 60 % f enfluramine-correct
responding 10 minutes after injection. It can also be seen that the
11
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Fig. 2. Percent of total responding on the fenfluramine lever as
a function of minutes since Injection. Rats were returned to their
home cages after Injections for the allotted time before testing
was carried out. Each point represents the mean ± 1 SEM for 10 rats.
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cue has a rather lengthy duration, the drug still 50 % effective
after 12 hours. It should be noted that between 30 and 120 min-
utes following drug injection, fenfluramine correct responding
was virtually perfect in all animals. Based on this data, all
future tests using fenfluramine were carried out 60 minutes fol-
lowing drug administration.
Experiment 2
,
The dose response relationship
.
Having clearly established the temporal parameters of the fen-
fluramine cue, I next generated a dose response curve for fenflur-
amine. Rats trained to discriminate 3 mg/kg fenfluramine from
saline were tested 60 minutes following injection of various doses
of drug.
From the data in Fig. 3, it can be seen that by varying the dose
of fenfluramine, a stimulus generalization curve is produced. The
percentage of responding on the fenfluramine lever decreased mono-
tonically as the dose of drug decreased.
It should be noted that a dose of 2 mg/kg fenfluramine elicits
97 % drug-correct responding. This "threshold dose", defined as the
lowest dose of drug capable of evoking reliable f enf luramine-correct
responding, would appear to be the appropriate dose to manipulate in
studies of fenfluramine antagonists. Attempting to antagonize a
larger dose of fenfluramine, would most likely require proportion-
ately larger doses of antagonists • The key in these antagonistic ex-
periments is to block the cue before reaching the point of drug-in-
duced behavioral suppression (i.e., toxic or non-specific effects).
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Fig. 3. Percent responding on the fenfluramine lever as a function
of dose. All Injections were given 1 hour prior to testing and
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t-test) from the fenfluramine 2 mg/kg value.
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For this reason, in all subsequent antagonistic studies, fenfluramine
2 mg/kg was the dose administered.
In order to monitor any changes in fenfluramine sensitivity
during the length of this experiment, 3 or 4 animals, randomly sel-
ected on each test day from the group of available subjects, re-
ceived a 2 mg/kg dose of fenfluramine. Fenfluramine-correct res-
ponding in these animals was virtually perfect throughout the course
of this study, with the median and mean daily values 100 and 97.4 %
respectively. This suggests that tolerance, as might be demon-
strated by a change in drug discrimination sensitivity, did not occur
with chronic administration of fenfluramine.
Experiment 3
,
Isomeric specificity of the fenfluramine cue .
In an attempt to explain the mechanism by which fenfluramine re-
duces central stores of brain 5-HT, an effect considered important in
its behavioral effects, Buczko et al. (1975) demonstrated that fen-
fluramine inhibits the uptake of 5-HT and induces its release by rat
blood platelets. Both effects were concentration dependent and in
both cases the (+) -isomer was more active than the (-) form. If this
neurochemical action of fenfluramine on the 5-HT system underlies the
behavioral effects of fenfluramine, then one might expect the dis-
criminative stimulus properties of fenfluramine to exhibit a similar
stereospecif icity
.
To this end, we investigated the stimulus generalization pro-
perties of the (+)-and (-)-isomeric forms of fenfluramine, 101.6
15
and 99.2 % pure respectively (UV analysis in ethanol solution by
Robins Research Laboratories),
Although at each of the 4 doses tested (see Fig. 4), the
(+)-isomer was more potent than the (-)-isomer at eliciting fen-
fluramine-correct responding, this difference was only significant
with the 2 mg/kg doses. Responding similar to the 2 mg/kg dose
of the raceme was produced by 2 mg/kg of the (+) form or 3 mg/kg
of the (-) form. Surprisingly, at no dose tested, was the (+)-
isomer significantly different from the racemic mixture at elicit-
ing fenfluramine-correct responding.
Our demonstration that the (+)-isomer of fenfluramine is more
effective than the (-)-isomer at inducing drug-correct responding
parallels the in vitro results of Buczko et al. (1975), supporting
the hypothesis that the 5-HT system might be involved in the dis-
criminative stimulus properties of fenfluramine.
Experiment 4
, Generalization of the fenfluramine cue .
The purpose of this phase of our experiment was to investigate
the pharmacological specificity of the fenfluramine cue. More
specifically, our attempt was to determine whether or not the qual-
itative aspects of the drug-produced interoceptive cue fall within
a specific pharamcological class . Therefore , various compounds
known to either enhance or diminish the effects of serotonin were
tested for their ability to generalize to the discriminative cue
produced from 3 mg/kg fenfluramine.
From the results presented in Table 1, it can be seen that of
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TABLE 1
DISCRIMINATIVE PROPERTIES OF FENFLURAMINE ANO RELATED OOMPOUNOS
Compound (•) Dos* n^ttf % Fenfluramine
( "9/k9> l«v«r selection 1
Fenfluramine (60) SO 24/24 97.4 t 1.9 b
Saline (60) *.u 24/ 24 1 • 1 t 1.3 a
Methyserql de (30) in / in 2.6 t 1.9 a
3.0 10/10 0.9 I 1.0 a
10 ay ia»/ TO 9.2 1 8.3 a
20 1A/1 AIU/ IU 3.9 t 2.8 a
40 a/ 1
1
3. 1 t 3.3 a
Clneneerln (30) 2.3 10/10 1.8 t 1.3 a
4 0?*v 0.0 t 0.0 a
10 10/10 11.1 i 9.4 a
20 10/12 0.9 t 1.0 a
30 8/11 4.4 t 3.1 a
Fluoxetine (60) 2.3 10/10 2.9 t 3.0 a
3.0 10/10 3.1 t 3.3 a
to 8/10 2.6 t 1.9 a
p^lnrneamjhalemlno 0.123 10/10 24.7 i 13.6 a b
(60) 0.23 10/10 39.1 t 16.8 • b
0.3 10/10 90.3 * 7.3 b
p-f 1 uoroemphetemlne 1.0 10/10 3.6 t 5.9 a
(60) 2.0 10/10 46.8 l 16.0 a b
3.0 9/13 44.0 t 14.6 a b
4.0 3/10 100 t 0.0 b
* Injection tin* prior to testing In minute*.
nr Number of animals showing sufficient responding (10 responses
on either lever) within « 10 minute extinction tett.
n* Number of animals tested.
q Each value represents the mean t 1 SEN of the number of animals
shoving sufficient responding at that dose.
Z ml /kg.
a Significantly different from the fenfluramine 3mg/kg value
( 1-talled; p<0.05; Student's t-test).
b Significantly different from the saline value ( 1-talled;
p<0.03; Students t-test).
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all the compounds tested, only p-chloroamphetamine (PCA) and p-
fluoroamphetamine (PFA)
,
two halogenated amphetamine derivatives
structurally related to fenfluramine, demonstrated any stimulus
generalization to the fenfluramine cue. It should be noted that
fluoxetine, methysergide and cinanserin, at all doses tested, in-
cluding doses inducing behavioral suppression, did not elicit fen-
fluramine-correct responding, suggesting that the animals were not
merely responding along a "drugged-not-drugged" continuum, but to
something more specific.
Upon closer examination (see Fig. 5), one can see that the
stimulus generalization gradients resulting from the administration
of PCA and PFA are monotonic and dose dependent. Only one-sixth of
the fenfluramine training dose is required for PCA to produce sig-
nificant generalization to the fenfluramine stimulus, whereas a 4 mg/kg
dose of PFA, slightly larger than the training dose of fenfluramine,
was required for reliable generalization. However, it should be
noted that only 3 of 10 animals tested with 4 mg/kg PFA responded
sufficiently, with the remainder not pressing either lever the re-
quisite 10 times within the 10 minute test period. These results il-
lustrate the high degree of chemical and pharmacological similarity
necessary for generalization to occur using this behavioral procedure,
but when equally effective doses are used, drugs with similar pharma-
cological actions are relatively indistinguishable from each other.
19
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Experiment 5, Antagonism of the fenfluraminp gug
In order to identify, somewhat more specifically, the pharma-
cological action upon which the discriminative stimulus property of
fenfluramine is based, an attempt was made to antagonize the fen-
fluramine cue with two types of agents; 5-HT receptor blockers and
a 5-HT reuptake inhibitor. Both the inhibition of 5-HT reuptake
and the inducement of its release increase the synaptic concentration
of 5-HT. If the resulting enhanced stimulation of 5-HT post-synaptic
receptors is instrumental in producing the discriminative cue, then
a 5-HT receptor blocker might be expected to antagonize or block the
cue. We therefore evaluated the effects of two putative 5-HT recep-
tor blockers, methysergide and cinanserin, on the discriminative
property of fenfluramine.
From the results illustrated in Figures 6 and 7 , it can be seen
that both methysergide and cinanserin, administered 30 minutes fol-
lowing injection of fenfluramine and 30 minutes prior to testing, an-
tagonized the fenfluramine cue. The antagonism was dose dependent and
the values were significantly different from the 2 mg/kg fenfluramine
only group for all but the lowest dose of each receptor blocker
tested. At no dose tested did the animals respond as if injected
with saline, indicating that the cue was not completely blocked,
merely significantly antagonized. This suggests that the availability
of 5-HT receptors to released transmitter substance is probably an
integral component, but not solely responsible for elicitation of
fenfluramine's discriminative cue.
21
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respectively.
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Experiment 6
, Fluoxetine-fenfluramine i.r.r^^
The precise mechanism of action of the 5-HT depletion resulting
from the administration of halogenated amphetamine derivatives such
as fenfluramine, PCA, or PFA is still not clear (presumably by in-
ducement of 5-HT release from nerve terminals), yet access of these
drugs to the 5-HT uptake pump for several hours appears necessary.
Fuller et al. (1974) reported that the preinjection of FXT or chlor-
imipramine (CMI)
,
selective and potent inhibitors of the 5-HT uptake
pump, blocked the 5-HT depletion induced by PCA. Not only was pre-
injection effective, but postinfection of CMI (Meek et al.
,
1971) or
FXT (Fuller et al.
,
1975) also effectively reversed the depletion.
In a similar experiment carried out in fenfluramine treated animals,
Clineschmidt et al. (1978) demonstrated that FXT can prevent (via
preinjection) or reverse (via postinjection) the 5-HT depletion
characteristic of fenfluramine.
In this experiment, an attempt was made to investigate the re-
quisite access of fenfluramine to the 5-HT uptake mechanism for elic-
itation of the fenfluramine cue. Therefore FXT was administered either
1 hour prior to, concurrently with, or 30 minutes following a 2 mg/kg
injection of fenfluramine.
In Fig. 8A it can be seen that FXT, when administered 1 hour
prior to fenfluramine, antagonized the discriminative cue. However
the dose relationship was inverse, with only the lower doses sig-
nificantly effective. When FXT was given concurrently with (see
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Fig. 8B) or 30 minutes following fenfluramine (see Fig. 8C)
, the
dose relationship is less clear. In both cases the 5 mg/kg dose
was the most potent at counteracting fenf luramine-correct responding,
but not significantly different from the 2.5 mg/kg dose.
Based on the ability of FXT to inhibit the uptake of fenflura-
mine into the presynaptic terminal, one might expect the 10 mg/kg
dose of FXT to be more potent than the 5 mg/kg dose at cue antagonism.
From Fig. 8 it can be seen that the 10 mg/kg dose of FXT, at all 3
times administered, is the least effective at blocking the discrim-
inative cue, with only the concurrent administration of 10 mg/kg FXT
demonstrating any significant antagonistic properties.
This apparent contradiction can perhaps be explained if one con-
siders the effect of FXT on the 5-HT system, irrespective of its
influence on fenfluramine. FXT, a blocker of 5-HT reuptake, increases
synaptic levels of transmitter substance, an agonistic property that
may only be evidenced with high doses of the reuptake inhibitor. For
example, a low dose of FXT, capable of blocking FEN uptake and thus
the fenfluramine-induced release of 5-HT, may itself not be sufficient
to enhance post-synaptic 5-HT activity via 5-HT uptake inhibition.
The result of the decreased release of 5-HT would be an insufficient
stimulation of 5-HT post-synaptic receptors, leading to saline lever
selection. On the other hand, a larger dose of FXT, clearly sufficient
to block the fenfluramine-induced release of 5-HT, may itself signifi-
cantly increase synaptic levels of 5-HT via a more pronounced inhibi-
tion of transmitter substance reuptake. The net effect in this case
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would be enhanced stimulation of 5-HT post-synaptic receptors and
eilcitation of the discriminative cue, leading to fenfluramine-
correct responding.
From this study it can be seen that FXT, a selective and po-
tent inhibitor of the 5-HT uptake mechanism, can antagonize the dis-
criminative stimulus properties of fenfluramine. It would appear
that the continued uptake of fenfluramine into the presynaptic nerve
terminal for a critical period of time is necessary for elicitation
of the discriminative cue. It may be that a substantial intra-
neural accumulation of fenfluramine needs to be achieved to pro-
vide the discriminative cue and FXT is able to interrupt this process.
With high doses of FXT, the situation is further complicated as FXT
may have a direct effect on the 5-HT system that counteracts the in-
fluence of FXT on fenfluramine.
Experiment 7
,
Is satiety the fenfluramine cue ?
Fenfluramine is clinically prescribed as an anorectic agent since
it reduces food intake, weight gain, and the subjective feeling of hun-
ger (Pinder et al., 1975). In our final experiment, we attempted to
evaluate the possible role of feelings of satiety as the basis of fen-
fluramine's discriminative cue. Therefore, animals were food deprived
either 0, 24, or 48 hours and tested following both saline and fenflur-
amine administration. During a 10 minute test period the following
measures were recorded: the latency of the first response, the number
of incorrect responses before the first reinforcement, and the total
number of responses during the 10 minute session.
The results were that all animals, when injected with either
saline or fenfluramine, regardless of their state of hunger, sel-
ected their appropriate levers at almost 100 % accuracy. If the
animal's state of hunger was the discriminative cue, then one might
have expected the animals injected with saline and food deprived
for 0 hours (satiated), to respond as if they had received an in-
jection of fenfluramine. Conversely, 48 hour food-deprived, fen-
fluramine-injected animals might have been expected to respond as
if they had been administered saline. Clearly this did not occur.
Cue detection, as evidenced by saline- or fenfluramine-correct lever
selection, was entirely independent of the state of hunger.
Moreover, as shown in Fig. 9A, the rate of food-reinforced
operant responding during the 10 minute session, under both treat-
ment conditions, did vary as a function of the length of food de-
privation. An analysis of variance for the overall food deprivation
effect was statistically significant (F = 20.39; df = 2, 18; p<0.001)
Although the response rate following saline administration was con-
sistently higher than that after injection of fenfluramine, the
difference was not significant (F = 2.92; df = 1,9; 0.1<p<0.2).
It can also be seen in Fig. 9B that under both treatment con-
ditions, the latency of the animal's initial response decreased as
the state of hunger was increased. An analysis of variance re-
vealed that this overall food deprivation effect was significant
(F = 1307; df = 2, 18; p<0.001). Regardless of the state of hunger,
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FOOD DEPRIVATION (HOURS)
Fig. 9. Rate of responding (A and C) and latency
of first response (B), as a function of length of
food deprivation. All animals were tested 1 hour
following Injection of saline or 3 mg/kg fenflur-
amine. Each point represents the mean ± 1 SEM for
the same 10 rats.
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erence
the latencies were consistently lower following saline admin
than after administration of fenfluramine. This overall diff
was highly significant (F = 104; df - 1, 9; p < 0.001).
Because first response latencies varied as a function of both the
drug treatment and the length of food deprivation, the actual time that
each animal spent lever pressing was not 10 minutes. Therefore, Fig.
9A does not accurately represent the rate of responding. To compen-
date for the effect of the drug and deprivation treatments on latencies,
response rates were recalculated for only the time interval subsequent
to each animal's initial response. This data is shown in Fig. 9C. It
can be seen that following this adjustment, the overall drug treat-
ment effect was now significant (F = 11.28; df = 1,9; p < 0.001). An
analysis of variance for the overall food deorivation effect contin-
ued to be highly significant (F = 20.07; df = 2, 18; p < 0.001). This
indicates that the observed differences in overall rate of responding
illustrated in Fig. 9A are not solely a result of the drug and depri-
vation effects on first response latencies.
These results demonstrate that although both the latency and rate
of operant responding vary as a function of the state of food
deprivation, lever selection occured independently of the state of
hunger. Under all conditions, each animal reliably selected the
appropriate lever. Therefore, our data do not support the hypothesis
that the feeling of satiety induced by fenfluramine is a factor in
the drugs ability to produce an interoceptive discriminative cue.
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GENERAL DISCUSSION
The control data obtained with the drug discrimination procedure
indicate that fenfluramine (3 mg/kg) may control differential operant
responding in rats on the basis of its discriminative stimulus prop-
erties. In this respect, the results are consistent with an earlier
study (Goudie, 1977) using fenfluramine at the same dose. It is
further shown that cue detection is optimal 30 and 120 minutes fol-
lowing administration of 3 mg/kg fenfluramine and is entirely inde-
pendent of its effects on appetite. It had also been demonstrated
that the lowest dose of drug capable of eliciting reliable discrimin-
ation is 2 mg/kg.
The generalization experiment with the isomeric forms of fen-
fluramine indicate that the (+)-isomer is more potent than the (-)-
form at eliciting fenfluramine-correct responding. This result
parallels the findings of Buczko et al. (1975), who demonstrated that
the (+)-form of fenfluramine was the more active at initiating the
release of 5-HT and inhibiting its reuptake by rat blood platelets.
Our results support the hypothesis that the 5-HT system is involved
in the discriminative stimulus properties of fenfluramine.
The generalization experiments with the serotonergic drugs pro-
vide evidence that of all the compounds tested, only the two halo-
genated amphetamine derivatives, structurally and pharmacologically
similar to fenfluramine, produce a discriminative stimulus which is
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generalized with the standard fenfluramine treatment in a dose-
dependent manner. This suggests that the discriminative stimulus
property of fenfluramine is pharmacologically specific.
The finding that drugs which block the binding sites for en-
dogenous serotonin also antagonize the fenfluramine cue, supports
the hypothesis that the discriminative stimulus property is based
upon fenfluramine's ability to enhance 5-HT transmission. This
suggests that the inhibition of 5-HT reuptake and the inducement of
its release by fenfluramine is not sufficient for elicitation of the
drug cue, but access of the released 5-HT to 5-HT receptors appears
necessary for discrimination to occur.
To further examine the involvement of the serotonergic system in
the discriminative property of fenfluramine, a selective and potent
inhibitor of 5-HT reuptake was tested for its effect on the fenfluramine
cue. Fluoxetine (FXT)
, administered either prior to, concurrently with
of following injection of fenfluramine, successfully antagonized the
discriminative cue, indicating that the continued access of fenfluramine
to the 5-HT reuptake mechanism is requisite for elicitation of the
fenfluramine cue. This finding is consistent with previous reports
demonstrating the ability of reuptake inhibitors to antagonize the 5-HT
depleting and anorectic effects of fenfluramine. This again suggests
that the behavioral effects of fenfluramine might be closely related to
the drugs ability to affect the serotonergic system.
It is important to note that the studies reported here in no way
allude to the locus of 5-HT action for the discriminative cue. Drug
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discrimination has been established on the basis of central (Colpaert
et al., 1975) and peripheral (Colpaert et al., 1976) effects of drugs.
It is also known that about 95% of the 5-HT in the body resides out-
side the central nervous system (Kety, 1967). To establish the locus
of the fenfluramine cue, one must either administer the drugs intra-
ventricular^ or use agents which selectively penetrate the blood
brain barrier.
In conclusion, the results reported here confirm the ability of
fenfluramine to produce a discriminative stimulus, enabling animals
to respond differentially to the drug and no-drug conditions. It has
further been demonstrated that the serotonergic system is intrinsically
involved in the discriminative stimulus properties of fenfluramine.
Finally, it is believed that the precision obtained in the test results
were dependent upon the early data generated by the time course and
dose response curves, that permitted the use of optimum doses and in-
jection times before testing.
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